Clinical Trials on Overactive Bladder Syndrome (OABS) in Hong Kong
Total 18 results
-
The University of Hong KongCompleted
-
The Hong Kong Polytechnic UniversityCompletedOveractive Bladder | Urgency Urinary IncontinenceHong Kong
-
KYU-SUNG LEEPfizerCompletedOveractive BladderKorea, Republic of
-
Imbrium TherapeuticsPurdue Pharma LPActive, not recruiting
-
GlaxoSmithKlineTerminatedOveractive Bladder | Incontinence, Urinary and Urinary Bladder, OveractiveUnited States
-
PfizerCompletedOveractive Bladder | Neurogenic Detrusor OveractivityUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina
-
PfizerCompletedOveractive BladderKorea, Republic of, Taiwan, Hong Kong, Japan
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
Targacept Inc.CompletedOveractive BladderUnited States
-
Urovant Sciences GmbHCompleted
-
PfizerCompletedOveractive BladderUnited States
-
NovartisProcter and GambleCompletedUrinary IncontinenceUnited States
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
Urovant Sciences GmbHActive, not recruitingOveractive BladderUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
IpsenTerminatedOveractive Bladder | Urinary IncontinenceUnited States, Korea, Republic of, Czechia, Netherlands, Romania, Poland, Turkey, Portugal, Canada, Italy